Ovarian Cancer Commitment (OCC)
The Ovarian Cancer Commitment (OCC) is a project initiated by the European Society of Gynaecological Oncology (ESGO), the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) and AstraZeneca.
The Digital Patient Pathway took inspiration from a gynaecological cancer online patient resource created by the ESGO/ENGAGe affiliate organisation Mallow Flower Foundation from Hungary.
We are committed to creating a movement in ovarian cancer care through highlighting the importance of improving access to rapid diagnosis, biomarker testing and specialised care, to ultimately facilitate the improvement of the quality of life of women* living with ovarian cancer.
The OCC will provide a platform to current and future partners to pledge their commitment and implement tangible actions to help improve the experience and survival of those living with ovarian cancer.
On October 28, 2022, the OCC launched the digital patient support resource for anyone affected by ovarian cancer.
For more information, please visit: www.ovariancancercommitment.com
“The OCC recognises the power of community and will act as a collective voice for everyone diagnosed with ovarian cancer, providing a vital opportunity for their views to be heard and connect people, information and resources. I do believe that together we can drive forward better outcomes.”
Petra Adamkova, Co-Chair, ENGAGe